Frontiers in Oncology, 2025
Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy

Uffenorde J., Hariri M., Papalanis E. et al.

Science Translational Medicine, 2025
Prior vaccination prevents overactivation of innate immune responses during COVID-19 breakthrough infection

Chan L., Pinedo K., Stabile M. et al.

Nature Communications, 2025
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment

Bolsewig K., Willemse E., Sánchez-Juan P. et al.

Atherosclerosis, 2025
Identifying novel drug targets for calcific aortic valve disease through Mendelian randomization

Xu D., Lu J., Yang Y. et al.

Current Issues in Molecular Biology, 2025
The Role of Cytokines and Chemokines as Biomarkers of Disease Activity in Idiopathic Nephrotic Syndrome in Children

Kopač M., Jerin A., Petrera A. et al.

International Journal of Molecular Sciences, 2025
Comparative Assessment of Acute Pulmonary Effects Induced by Heat-Not-Burn Tobacco Aerosol Inhalation in a Murine Model

Kim B., Yang W., Seong Y. et al.

Frontiers in Immunology, 2025
Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in cystic fibrosis

Ozuna H., Bojja D., Partida-Sanchez S. et al.

Journal for ImmunoTherapy of Cancer, 2025
Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial

Pakola S., Clubb J., Kudling T. et al.

Scientific Reports, 2025
Interconnections between BDH1-plasma protein-type 2 diabetes Mellitus: a mediated mendelian randomization analysis using plasma proteomics

Liu Y., Zhang Y., Wan Q.

The FASEB Journal, 2025
Novel inflammatory markers in intracerebral hemorrhage: Results from Olink proteomics analysis

Hu Z., Chen S., Zhang E. et al.

CHEST Critical Care, 2025
Immunomodulation for acute respiratory distress syndrome: insights from proteomics in COVID-19

Rademaker E., Haitsma Mulier J., Drylewicz J. et al.

Pediatric Research, 2025
Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls

Buonsenso D., Cotugno N., Amodio D. et al.

British Journal of Dermatology, 2025
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)

Silverberg J., Eichenfield L., Blauvelt A. et al.

European Heart Journal, 2025
Mosaic loss of Y chromosome and mortality after coronary angiography

Weyrich M., Zewinger S., Sarakpi T. et al.

Journal of Translational Medicine, 2025
Multi-omics analysis reveals novel causal pathways in psoriasis pathogenesis

Guo H., Gao J., Gong L. et al.

Biomolecules, 2025
A Genetic and Environmental Analysis of Inflammatory Factors in Chronic Widespread Pain Using the TwinsUK Cohort

Cherny S., Livshits G., Williams F.

Hepatology International, 2025
Non-canonical Wnt signaling pathway activated NFATC3 promotes GDF15 expression in MASH: prospective analyses of UK biobank proteomic data

Wang H., Xu X., Shi L. et al.

European Journal of Heart Failure, 2025
Circulating growth differentiation factor‐15 levels are associated with early echocardiographic signs of diastolic function impairment in the STANISLAS cohort: A 20‐year follow‐up study

Monzo L., Xhaard C., Ferreira J. et al.

Clinical Proteomics, 2025
ARTN and CCL23 predicted chemosensitivity in acute myeloid leukemia: an Olink® proteomics approach

Wu T., Hsiao T., Chen C. et al.

American Journal of Physiology-Heart and Circulatory Physiology, 2025
Chemerin is a new sex-specific target in aortic stenosis concomitant with diabetes regulated by the aldosterone/mineralocorticoid receptor axis

Goñi-Olóriz M., Garaikoetxea Zubillaga M., San Ildefonso-García S. et al.